Virtual family therapy may tame schizophrenia symptoms — a trial investigates

NCT ID NCT07121166

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a six-week online group program, combining cognitive behavioural therapy with family support, can help people with schizophrenia and their caregivers. Researchers will measure changes in symptoms, expressed emotion, and caregiver mood. The study includes 200 dyads and uses both surveys and interviews to gauge effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a six-week online group cognitive behavioural family intervention (tgCBFI) for people with schizophrenia and their family caregivers
What this could lead to
If effective, this online program could offer a scalable way to improve symptoms and reduce caregiver stress without in-person visits.
What could go wrong
This is a relatively small trial with a short follow-up, and the benefits may not last or apply to all families. The intervention requires internet access and Chinese literacy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

I. Individuals with schizophrenia-spectrum disorders Inclusion Criteria: * current diagnosis of schizophrenia-spectrum disorders, based on ICD-10 made by the treating clinicians, * aged 18-64, and * able to read and write Chinese Exclusion Criteria: * having co-morbidity of learning disability, organic/neurological conditions, or substance use disorder, and * living in a hostel II. Family caregivers Inclusion Criteria: * aged 18 or above, * able to read and write Chinese, * live with service users, and * nominated by the service users Exclusion Criteria: * having active psychiatric conditions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Schizophrenia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ALOHA (Eastern)

    RECRUITING

    Chai Wan, Hong Kong

  • ALOHA (Wong Tai Sin)

    RECRUITING

    Tsz Wan Shan, Hong Kong

  • Kowloon Hospital

    RECRUITING

    Kowloon City, Hong Kong

  • Kwai Chung Hospital

    RECRUITING

    Kwai Chung, Hong Kong

  • Queen Mary Hospital

    RECRUITING

    Pokfulam, Hong Kong

  • United Christian Hospital

    RECRUITING

    Kwun Tong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.